Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2014

Nov 13, 2014

34975_dirs_2014-11-13_01b4043e-9fde-46c6-819c-ce9d0f50e9ab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-11-13

Reporting Person: LOY BERTRAND (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-13 Non-Qualified Stock Option (right to buy) $4.84 A 55300 Acquired 2024-11-13 Common Stock, par value $0.01 per share (55300) Direct

Footnotes

F1: The options vest in three equal installments on November 13, 2015, 2016 and 2017.